Submitted by Anonymous (not verified) on 23 March 2026 - 15:12
Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tremfya, guselkumab, Date of authorisation: 10/11/2017, Revision: 16, Status: Authorised